Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
51,335,037
-
Share change
-
-268,034
-
Total reported value
-
$41,591,047
-
Price per share
-
$0.8102
-
Number of holders
-
53
-
Value change
-
-$36,555
-
Number of buys
-
24
-
Number of sells
-
17
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q3 2025
As of 30 Sep 2025 Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,335,037 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, Carlyle Group Inc., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, REGENERON PHARMACEUTICALS, INC., and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This table shows 53 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.